Parkinsonian syndrome: causes, features, diagnosis and management

Core clinical features

Patients with parkinsonian syndrome typically show some combination of the following motor signs. These features form the basis for clinical identification:

• Tremor: usually a resting tremor that may lessen with movement; other tremor patterns are possible (tremor).
• Bradykinesia (hypokinesia): slowness of movement and reduced spontaneous movement.
• Rigidity: increased muscle tone causing stiffness.
• Postural instability: impaired balance and increased risk of falls.

Nonmotor features such as changes in mood, sleep, autonomic function and cognition often accompany the movement signs and can help distinguish underlying causes.

Causes and important distinctions

Parkinsonism can be classified by origin. The most common single cause is Parkinson's disease, a progressive neurodegenerative disorder. However, other categories include:

1. Drug-induced parkinsonism: a frequent and potentially reversible cause due to medications that block dopamine pathways. Antipsychotics and related agents are prominent examples; discussion and examples are available for many commonly implicated drugs (medications).
2. Secondary causes: toxins, metabolic disorders, infections or vascular lesions that damage relevant brain regions.
3. Atypical parkinsonian disorders: progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration—conditions with overlapping symptoms but distinct pathological and prognostic features.

Common antipsychotic classes such as phenothiazines, thioxanthenes and butyrophenones have been associated with drug-induced parkinsonism; some specific examples include agents historically used in psychiatry and neurology (example drugs).

Diagnosis

Diagnosis begins with a careful clinical history and neurological examination. Key considerations include the pattern and progression of signs, onset relative to drug exposure, response to dopaminergic medications, and presence of atypical features such as early falls or rapid cognitive decline. Imaging and laboratory tests are used to exclude alternative causes and to support the clinical impression in uncertain cases.

Treatment and management

Management depends on the cause. If a medication is responsible, reducing or substituting the offending drug often improves symptoms. In degenerative causes like Parkinson's disease, symptomatic treatments—particularly dopaminergic therapy—can reduce motor disability but do not halt disease progression. A multidisciplinary approach that includes physical therapy, occupational therapy, speech therapy and management of nonmotor symptoms improves quality of life. For atypical parkinsonian disorders, therapy focuses on supportive care and targeted symptom relief.

Prognosis and notable facts

The outlook varies widely: drug-induced parkinsonism may be reversible, while neurodegenerative forms typically progress over years. Distinguishing Parkinson's disease from other parkinsonian syndromes is important because it affects prognosis, treatment choices and counseling. Because many causes exist, clinicians often emphasize detailed medication review and open communication about symptom evolution to guide diagnosis and care.

For further reading and clinical resources see general neurology references and condition-specific reviews (neurology overview, Parkinson's disease resources, drug safety information).